Personal information

Websites & social links

ResearchGate

Other IDs

Loop profile: 798895
Scopus Author ID: 57191412572

Countries

Greece

Activities

Collapse all

Employment (8)

de Duve Institute: Brussels, BE

2021 to present | PostDoctoral Fellow
Employment
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens - Faculty of Medicine: : Athens, GR

2020-01 to 2021-02 | Research Associate (Molecular Oncology Unit, Department of Biological Chemistry)
Employment
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens: Athens, GR

2014-11 to 2019-12 | PhD Thesis Project (Molecular Oncology Unit, Department of Biological Chemistry)
Employment
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens - Faculty of Medicine: Athens, GR

2014 to 2019 | Research Associate (Department of Biological Chemistry)
Employment
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens - Faculty of Medicine: Athens, GR

2014-10 to 2015-08 | Master Thesis Project (Molecular Oncology Unit, Department of Biological Chemistry)
Employment
Source: Self-asserted source
Ilianna Zoi

Biomedical Research Foundation of the Academy of Athens: Athens, GR

2014-06 to 2014-09 | Rotation Internship (Bioinformatics and Medical Informatics Laboratory, Center of Systems Biology)
Employment
Source: Self-asserted source
Ilianna Zoi

Biomedical Research Foundation of the Academy of Athens: Athens, GR

2014-02 to 2014-06 | Rotation Internship (Neurophysiology Laboratory, Center of Basic Research)
Employment
Source: Self-asserted source
Ilianna Zoi

National Centre for Scientific Research-Demokritos: Athens, GR

2012-09 to 2013-09 | Dissertation Thesis Project (Microbial Molecular Genetics Laboratory, Institute of Biosciences and Applications)
Employment
Source: Self-asserted source
Ilianna Zoi

Education and qualifications (3)

National and Kapodistrian University of Athens - Faculty of Medicine: Athens, GR

2014 to 2019 | PhD (Biological Chemistry)
Education
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens: Athens, Attiki, GR

2014 to 2016 | Master of Science
Education
Source: Self-asserted source
Ilianna Zoi

National and Kapodistrian University of Athens Faculty of Biology: Athens, GR

2008 to 2014 | Diploma Degree in Biology
Education
Source: Self-asserted source
Ilianna Zoi

Professional activities (5)

Healthcare Business Awards 2021: Athens, GR

2021 | Gold Award in Research project category
Distinction
Source: Self-asserted source
Ilianna Zoi

Australian Government Australia Awards: Athens, GR

2021 | Platinum Award in Research project category
Distinction
Source: Self-asserted source
Ilianna Zoi

Hellenic Society of Medical Oncology: Athens, GR

2019-04 | Best Poster Award (25th Hellenic Congress of Clinical Oncology)
Distinction
Source: Self-asserted source
Ilianna Zoi

Hellenic Society for Paediatric Infectious Diseases: Athens, GR

2018-12 | Best Paper Award (1st PanHellenic Congress of Pediatric Infections)
Distinction
Source: Self-asserted source
Ilianna Zoi

Hellenic Endocrine Society: Athens, GR

2018-05 | "Georgios Tolis" Prize (45th Panhellenic Congress of Endocrinology, Metabolism & Diabetes)
Distinction
Source: Self-asserted source
Ilianna Zoi

Funding (3)

Post-doctoral fellowship from the de Duve Institute

2021 to 2022 | Grant
de Duve Institute (Brussels, BE)
Source: Self-asserted source
Ilianna Zoi

“Supporting researchers with an emphasis on young researchers”. The project is co-financed by Greece and the European Union (European Social Fund – ESF) by the Operational Programme Human Resources Development, Education and Lifelong Learning 2014-20

2020 to 2021 | Grant
European Social Fund – ESF (Athens, GR)
Source: Self-asserted source
Ilianna Zoi

Scholarship of the project “Scholarships programme for postgraduate studies - 2nd Study Cycle”, implemented by the State Scholarships Foundation (ΙΚΥ).

2017 to 2019 | Grant
State Scholarships Foundation (Athens, GR)
Source: Self-asserted source
Ilianna Zoi

Works (13)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro

Journal of Cellular and Molecular Medicine
2022-03 | Journal article
DOI: 10.1111/jcmm.17212
Contributors: Ilianna Zoi; Antonios N. Gargalionis; Kostas A. Papavassiliou; Narjes Nasiri‐Ansari; Christina Piperi; Efthimia K. Basdra; Athanasios G. Papavassiliou
Source: check_circle
Crossref

Low IL-23 levels in peripheral blood and bone marrow at diagnosis of acute leukemia in children increased with the elimination of leukemic burden.

Journal of cellular and molecular medicine
2021-07-08 | Journal article
DOI: 10.1111/jcmm.16772
PMID: 34235838
PMC: PMC8335666
Source: Self-asserted source
Ilianna Zoi

Polycystin-1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model.

Journal of cellular and molecular medicine
2021-03-03 | Journal article
DOI: 10.1111/jcmm.16391
PMID: 33656806
PMC: PMC8034462
Source: Self-asserted source
Ilianna Zoi

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights

Molecules
2020-01-15 | Journal article
DOI: 10.3390/molecules25020358
Contributors: Aristomenis Anestis; Ilianna Zoi; Athanasios G. Papavassiliou; Michalis V. Karamouzis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas.

Breast cancer research : BCR
2019-12-03 | Journal article
DOI: 10.1186/s13058-019-1226-9
PMID: 31796128
PMC: PMC6892243
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 2)‎

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines

Journal of Cellular and Molecular Medicine
2019-09 | Journal article
DOI: 10.1111/jcmm.14506
Part of ISSN: 1582-1838
Part of ISSN: 1582-4934
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 2)‎

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer

Journal of Cancer Research and Clinical Oncology
2019-05 | Journal article
DOI: 10.1007/s00432-019-02872-9
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 2)‎

Combining denosumab (D) and trastuzumab (T) as a novel treatment strategy in HER2-positive (+) breast carcinomas (BC).

Journal of Clinical Oncology
2019-05-20 | Journal article
DOI: 10.1200/jco.2019.37.15_suppl.e12506
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Ilianna Zoi

66PDual targeting of RANKL/RANK pathway and HER-2 as a novel treatment strategy in HER-2 positive (+) breast carcinomas (BC)

Annals of Oncology
2019-05-01 | Journal article
DOI: 10.1093/annonc/mdz095.065
Part of ISSN: 0923-7534
Part of ISSN: 1569-8041
Source: Self-asserted source
Ilianna Zoi

Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients

International Journal of Molecular Sciences
2019-02-21 | Journal article
DOI: 10.3390/ijms20040937
Part of ISSN: 1422-0067
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 3)‎

Current advances of targeting HGF/c-Met pathway in gastric cancer

Annals of Translational Medicine
2018-06 | Journal article
DOI: 10.21037/atm.2018.04.42
Part of ISSN: 2305-5839
Part of ISSN: 2305-5847
Source: Self-asserted source
Ilianna Zoi

Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis

Cellular and Molecular Life Sciences
2017-03 | Journal article
DOI: 10.1007/s00018-016-2394-8
Part of ISSN: 1420-682X
Part of ISSN: 1420-9071
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 2)‎

RANKL Signaling and ErbB Receptors in Breast Carcinogenesis

Trends in Molecular Medicine
2016-10 | Journal article
DOI: 10.1016/j.molmed.2016.07.009
Part of ISSN: 1471-4914
Source: Self-asserted source
Ilianna Zoi
grade
Preferred source (of 2)‎
How many people are using ORCID?